Microdialysis as Clinical Evaluation of Therapeutic Hypothermia in Rat Subdural Hematoma Model.
Cerebral microdialysis (MD) is a fine laboratory technique which has been established for studying physiological, pharmacological, and pathological changes in the experimental studies of traumatic brain injury (TBI). This technique has also been well translated and widely applied to clinical bedside monitoring to provide pathophysiological analysis in severe TBI patients. The MD technique is thus well suited for straightforward translation from basic science to clinical application.In this chapter, we describe our evaluation of MD method in acute subdural hematoma (ASDH) rat model. With 100 kDa cut-off microdialysis membrane, we could measure several biomarkers such as ubiquitin carboxy hydrolase L1 (UCH-L1), a neuronal marker and glial fibrillary acidic protein (GFAP), and a glial marker in extracellular fluid. In this experiment, we could detect that the peak of extracellular UCH-L1 in the early hypothermia group was significantly lower than in the normothermia group. Also, in the late phase of reperfusion (>2.5 h after decompression), extracellular GFAP in the early hypothermia group was lower than in the normothermia. These data thus suggested that early, preoperatively induced hypothermia could mediate the reduction of neuronal and glial damage in the reperfusion phase of ischemia/reperfusion brain injury.Microdialysis allows for the direct measurement of extracellular molecules in an attempt to characterize metabolic derangements before they become clinically relevant. Advancements in technology have allowed for the bedside assay of multiple markers of ischemia and metabolic dysfunction, and the applications for traumatic brain injury have been well established. As clinicians become more comfortable with these tools their widespread use and potential for clinical impact with continue to rise.
Department of Emergency and Critical Care Medicine, Nippon Medical School, 1-1-5, Sendagi, Bunkyo-ku, Tokyo, 113-8603, Japan. shoji@nms.ac.jp.
Shoji
S
Yokobori
Department of Neurosurgery, University of Miami Miller School of Medicine, Miami, FL, USA.
Markus S
MS
Spurlock
Department of Neurosurgery, University of Miami Miller School of Medicine, Miami, FL, USA.
Stephanie W
SW
Lee
Department of Neurosurgery, University of Miami Miller School of Medicine, Miami, FL, USA.
Shyam
S
Gajavelli
Department of Neurosurgery, University of Miami Miller School of Medicine, Miami, FL, USA.
Ross M
RM
Bullock
D000818:Animals; D015415:Biomarkers; D000070642:Brain Injuries, Traumatic / Q000150:complications; D016207:Cytokines / Q000378:metabolism; D004195:Disease Models, Animal; D045604:Extracellular Fluid / Q000378:metabolism; D006408:Hematoma, Subdural / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy*; D007036:Hypothermia, Induced / Q000295:instrumentation / Q000379:methods; D008297:Male; D017551:Microdialysis / Q000295:instrumentation / Q000379:methods; D051381:Rats; D057170:Translational Research, Biomedical
D015415:Biomarkers; D016207:Cytokines
Experimental model; Microdialysis; Pathophysiology; Subdural hematoma; Therapeutic hypothermia; Traumatic brain injury